4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-046833
Chief Financial Officer gave up 2,117 shares (to pay taxes)
- Chief Financial Officer acquired 5,433 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-08-18 | Option exercise | +1,752 | 103,520 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-08-18 | Shares withheld for taxes | −683 | $8.46 | $5,778 | 102,837 | D |
| Jeanmonod Patrik Chief Financial Officer | 2023-08-18 | Option exercise | +3,681 | 106,518 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-08-18 | Shares withheld for taxes | −1,434 | $8.46 | $12,132 | 105,084 | D |
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2023-08-18 | Option exercise · Restricted Stock Units | −1,752 | 16,946 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-08-18 | Option exercise · Restricted Stock Units | −3,681 | 52,771 | D | ||
Loading xslF345X05/doc4.xml…